- Cancer Cytogenetics: Methodology Revisited
-
Wan TS
- KMID: 2129566
- Ann Lab Med.
- 2014 Nov;34(6):413-425.
- doi: 10.3343/alm.2014.34.6.413
The Philadelphia chromosome was the first genetic abnormality discovered in cancer (in 1960), and it was found to be consistently associated with CML. The description of the Philadelphia chromosome ushered... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers
-
Suh EJ, Kabir MH, Kang UB, Lee JW, Yu J, Noh DY, Lee C
- KMID: 1120140
- Exp Mol Med.
- 2012 Jan;44(1):36-44.
- doi: 10.3858/emm.2012.44.1.003
Breast cancer is the most common cancer in women worldwide. It is necessary to identify biomarkers for early detection, to make accurate prognoses, and to monitor for any recurrence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer
-
Lawicki S, Glazewska , Sobolewska M, Bedkowska , Szmitkowski M
- KMID: 2373531
- Ann Lab Med.
- 2016 May;36(3):223-229.
- doi: 10.3343/alm.2016.36.3.223
BACKGROUND: Macrophage colony-stimulating factor (M-CSF), matrix metalloproteinase-9 (MMP-9), and its specific tissue inhibitor - tissue inhibitor of metalloproteinases-1 (TIMP-1) may play an important role in the pathogenesis and spread of... -
- CITED
-
- Close
- SHARE
-
- Close
